Have your own idea? Try our Stock Screener
Israeli (TA) Biotech Industry Analysis
UpdatedApr 30, 2026
DataAggregated Company Financials
Companies11
- 7D-2.8%
- 3M-7.8%
- 1Y3.4%
- YTDn/a
Over the last 7 days, the Biotech industry has dropped 2.6%, driven by Kamada declining 2.8%. On the other hand XTL Biopharmaceuticals is actually up 30%. In the past year, the industry has gained 3.6%. Looking forward, earnings are forecast to grow by 14% annually.
Industry Valuation and Performance
Has the Israeli Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 30 Apr 2026 | ₪2.3b | ₪555.4m | -₪57,810,020.60 | 7x | -40.3x | 4.2x |
| Sat, 28 Mar 2026 | ₪2.4b | ₪585.8m | -₪73,088,443.80 | 14.3x | -32.3x | 4x |
| Mon, 23 Feb 2026 | ₪2.7b | ₪610.9m | -₪60,160,271.80 | 15.3x | -44.6x | 4.4x |
| Wed, 21 Jan 2026 | ₪2.6b | ₪619.4m | -₪60,248,256.60 | 13.8x | -42.5x | 4.1x |
| Fri, 19 Dec 2025 | ₪2.2b | ₪633.4m | -₪66,560,720.50 | 13x | -32.9x | 3.5x |
| Sun, 16 Nov 2025 | ₪2.1b | ₪657.4m | -₪89,067,306.10 | 12.7x | -23.7x | 3.2x |
| Tue, 14 Oct 2025 | ₪2.1b | ₪650.5m | -₪94,285,261.00 | 13x | -22.6x | 3.3x |
| Thu, 11 Sep 2025 | ₪2.3b | ₪661.0m | -₪97,232,810.00 | 13.3x | -23.3x | 3.4x |
| Sat, 09 Aug 2025 | ₪2.2b | ₪682.0m | -₪129,488,678.90 | 15.4x | -17.1x | 3.3x |
| Mon, 07 Jul 2025 | ₪2.3b | ₪664.8m | -₪128,489,977.30 | 16.3x | -17.6x | 3.4x |
| Wed, 04 Jun 2025 | ₪2.2b | ₪699.3m | -₪130,493,107.00 | 14.5x | -16.6x | 3.1x |
| Fri, 02 May 2025 | ₪2.1b | ₪724.7m | -₪163,177,024.00 | 15.6x | -13.2x | 3x |
| Sun, 30 Mar 2025 | ₪2.2b | ₪715.4m | -₪220,547,643.20 | 16.1x | -10.1x | 3.1x |
| Tue, 25 Feb 2025 | ₪2.2b | ₪679.7m | -₪227,549,242.00 | 16.1x | -9.9x | 3.3x |
| Thu, 23 Jan 2025 | ₪2.2b | ₪672.1m | -₪226,085,329.00 | 16.5x | -9.8x | 3.3x |
| Sat, 21 Dec 2024 | ₪1.9b | ₪691.4m | -₪227,351,426.40 | 13.7x | -8.4x | 2.8x |
| Mon, 18 Nov 2024 | ₪2.1b | ₪700.2m | -₪255,373,146.50 | 13.6x | -8.1x | 3x |
| Wed, 16 Oct 2024 | ₪2.0b | ₪688.4m | -₪258,337,684.40 | 13x | -7.8x | 2.9x |
| Fri, 13 Sep 2024 | ₪2.1b | ₪681.4m | -₪256,567,398.90 | 13.2x | -8.1x | 3.1x |
| Sun, 11 Aug 2024 | ₪2.1b | ₪643.8m | -₪330,863,611.10 | 16.7x | -6.2x | 3.2x |
| Tue, 09 Jul 2024 | ₪2.1b | ₪635.9m | -₪327,806,932.10 | 17.2x | -6.5x | 3.4x |
| Thu, 06 Jun 2024 | ₪2.1b | ₪639.6m | -₪331,374,115.70 | 15.8x | -6.2x | 3.2x |
| Sat, 04 May 2024 | ₪2.1b | ₪572.1m | -₪402,314,562.50 | 23.1x | -5.3x | 3.7x |
| Mon, 01 Apr 2024 | ₪2.3b | ₪571.7m | -₪382,715,538.80 | 22.7x | -6x | 4x |
| Wed, 28 Feb 2024 | ₪2.5b | ₪577.1m | -₪363,155,750.00 | 63.3x | -6.9x | 4.3x |
| Fri, 26 Jan 2024 | ₪2.3b | ₪633.6m | -₪401,559,308.00 | 58.2x | -5.7x | 3.6x |
| Sun, 24 Dec 2023 | ₪2.4b | ₪618.6m | -₪394,159,196.00 | 62.4x | -6x | 3.8x |
| Tue, 21 Nov 2023 | ₪2.1b | ₪637.0m | -₪382,497,030.00 | 52.9x | -5.6x | 3.3x |
| Thu, 19 Oct 2023 | ₪2.1b | ₪648.8m | -₪427,430,955.00 | 73.2x | -4.8x | 3.2x |
| Sat, 16 Sep 2023 | ₪2.2b | ₪621.2m | -₪381,289,068.00 | 71.4x | -5.9x | 3.6x |
| Mon, 14 Aug 2023 | ₪1.9b | ₪553.4m | -₪394,409,361.00 | 60.3x | -4.8x | 3.4x |
| Wed, 12 Jul 2023 | ₪1.9b | ₪546.1m | -₪394,276,804.00 | n/a | -4.9x | 3.5x |
| Fri, 09 Jun 2023 | ₪1.9b | ₪542.1m | -₪392,111,374.00 | n/a | -4.8x | 3.5x |
| Sun, 07 May 2023 | ₪1.7b | ₪529.2m | -₪366,212,297.00 | n/a | -4.7x | 3.2x |
Price to Earnings Ratio
-4.7x
Current Industry PE
- Investors are optimistic on the Israeli Biotechnology industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 3.4x is lower than the industry's current PS ratio of 4.2x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have improved over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that companies overall are more efficiently conducting business since losses are shrinking while sales have been flat.
Industry Comparison
How does Israeli Biotech compare with similar industries?
| IL Market | 0.80% | |
| Healthcare | -1.88% | |
| Biotech | -2.83% | |
| Biotech | -2.83% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| XTLB XTL Biopharmaceuticals | ₪0.026 | 30.0% +₪5.7m | -46.9% | PS8.5x | |
| GFC-M G.F.C Green Fields Capital | ₪15.50 | 1.6% +₪2.5m | 21.2% | PE7x | |
| NXTG-M Nextage Therapeutics | ₪0.45 | 17.6% +₪2.3m | -57.2% | PE5.3x | |
| CBI Clal Biotechnology Industries | ₪0.34 | 3.7% +₪1.9m | -1.2% | PB2.6x | |
| GRAC Grace Breeding | ₪18.00 | 2.3% +₪1.7m | -7.7% | PB52.4x |